MedTrace Logo

Early Genetic Identification of Obesity

NCT06239064 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-09-29

No results posted yet for this study

Summary

TITLE: Whole genetic approach in Early Genetic Identification of Obesity (WEGIO)

DESIGN: Multicenter epidemiological study

STUDY POPULATION: Participants at risk for a syndromic or a monogenic genetic obesity, incl. participants clinically diagnosed with Bardet-Biedl-Syndrome (BBS)

NUMBER OF PARTICIPANTS: 1000 for initial genetic sequencing and app. 40 for the follow-up documentation

COORDINATING INVESTIGATOR: Prof. Dr. Arndt Rolfs

Conditions

Interventions

DIAGNOSTIC_TEST

Genetic testing via blood collection

blood collection

Sponsors & Collaborators

  • Rhythm Pharmaceuticals, Inc.

    collaborator INDUSTRY

  • Rolfs Consulting und Verwaltungs-GmbH (RCV)

    lead NETWORK

Principal Investigators

  • Arndt Rolfs, PhD, MD · Rolfs Consulting und Verwaltungs-GmbH (RCV)

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-24
Primary Completion
2026-03-01
Completion
2027-03-01

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06239064 on ClinicalTrials.gov